CVE-2023-40153
CVE-2023-40153 is a medium-severity vulnerability in Dexma Dexgate with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.
Key facts
- Severity: Medium (CVSS 3.x base score 5.4)
- EPSS exploit prediction: 0% (21st percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-79
- Affected product: Dexma Dexgate
- Published:
- Last modified:
Description
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
Frequently asked questions
- What is CVE-2023-40153?
- The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
- How severe is CVE-2023-40153?
- CVE-2023-40153 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
- Is CVE-2023-40153 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (21st percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-40153?
- CVE-2023-40153 affects Dexma Dexgate. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-40153?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2023-40153 published?
- CVE-2023-40153 was published on 2023-10-19 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:dexma:dexgate:20130114:*:*:*:*:*:*:*
More vulnerabilities in Dexma Dexgate
- CVE-2023-41089 — High (CVSS 8.0): The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to…
- CVE-2023-41088 — Medium (CVSS 6.3): The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow…
- CVE-2023-42435 — Medium (CVSS 5.5): The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to…
- CVE-2023-42666 — Medium (CVSS 5.3): The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability,…
All CVEs affecting Dexma Dexgate →
Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities
- CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
- CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
- CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
- CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
- CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
- CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…
Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →